Liminatus Pharma LLC(LIMN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LIMN Liminatus Pharma LLC

Not Yet Opened 05-14 16:00:00 EDT

0.1840

-0.0010

-0.54%

盘后0.1899

+0.0059+3.21%

19:30 EDT

High0.1900	Low0.1810	Vol529.31K
Open0.1871	D1 Closing0.1850	Amplitude4.86%
Mkt Cap8.26M	Tradable Cap1.76M	Total Shares44.88M
T/O97.94K	T/O Rate5.54%	Tradable Shares9.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LIMN","market":"US","secType":"STK","nameCN":"Liminatus Pharma LLC","latestPrice":0.184,"timestamp":1778788800000,"preClose":0.185,"halted":0,"volume":529312,"hourTrading":{"tag":"盘后","latestPrice":0.1899,"preClose":0.184,"latestTime":"19:30 EDT","volume":30764,"amount":5673.1225,"timestamp":1778801407231,"change":0.0059,"changeRate":0.032065,"amplitude":0.040761},"delay":0,"changeRate":-0.00540540540540541,"floatShares":9555200,"shares":44877600,"eps":-0.429683,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"05-14 16:00:00 EDT","open":0.1871,"high":0.19,"low":0.181,"amount":97943.2043744,"amplitude":0.048649,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.429683,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1778832000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.185,"preHourTrading":{"tag":"盘前","latestPrice":0.1879,"preClose":0.185,"latestTime":"08:23 EDT","volume":26176,"amount":4818.0186912,"timestamp":1778761418813,"change":0.0029,"changeRate":0.015676,"amplitude":0.083784},"postHourTrading":{"tag":"盘后","latestPrice":0.1899,"preClose":0.184,"latestTime":"19:30 EDT","volume":30764,"amount":5673.1225,"timestamp":1778801407231,"change":0.0059,"changeRate":0.032065,"amplitude":0.040761},"volumeRatio":0.82992},"requestUrl":"/m/hq/s/LIMN/wiki","defaultTab":"wiki","newsList":[{"id":"2624553495","title":"Liminatus Pharma FY25 net loss widens to $10.2 million; operating loss narrows to $3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624553495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624553495?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:31","pubTimestamp":1774992668,"startTime":"0","endTime":"0","summary":"Liminatus Pharma posted a net loss of $10.2 million for fiscal 2025.General and administrative expense climbed to $3 million, driven by higher accounting and legal costs tied to the business combination and operating as a public company.Management flagged substantial doubt about its ability to continue as a going concern, planning to raise additional cash through equity or debt financings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL3yt0PX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620424361","title":"Liminatus Pharma plans Phase 1 trial of CD47 antibody IBA101 in lung cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2620424361","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620424361?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:08","pubTimestamp":1773749309,"startTime":"0","endTime":"0","summary":"Liminatus Pharma announced plans to initiate a Phase 1 clinical trial of IBA101, a CD47-blocking monoclonal antibody. The study is designed to start with monotherapy dose escalation assessing safety, tolerability, and pharmacokinetics, followed by combination cohorts with PD-1/PD-L1 therapies within the same protocol. Lung cancer is the initial focus for the Phase 1 program. The trial is planned to be led by Se-Hoon Lee and will include translational analyses of immune activity and biological features associated with clinical benefit. No clinical results have been presented, and none were stated as scheduled for future presentation.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLpJLjN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210150020.SGD","SG9999014039.USD","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014021.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4588","LU0314104364.USD","SG9999014005.SGD","NDAQ","IE00B64PRP62.GBP","BK4139","LIMN","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620424358","title":"Liminatus Pharma Announces Planned Phase 1 Clinical Trial of Iba101, a Next-Generation Cd47 Blocking Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2620424358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620424358?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:08","pubTimestamp":1773749280,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUABT7J4H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617556946","title":"Liminatus Pharma Cuts Shareholder Meeting Quorum to One-Third","url":"https://stock-news.laohu8.com/highlight/detail?id=2617556946","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617556946?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:17","pubTimestamp":1772659067,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc.’s board approved an amendment to the company’s bylaws lowering the stockholder meeting quorum requirement from a majority to one-third of the voting power of outstanding shares entitled to vote. The change took effect immediately and will be submitted for stockholder ratification at the next annual meeting, though the board may keep the amendment even if stockholders do not approve it under Delaware law.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 04, 2026, and is solely responsible for th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL7mdvV6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612450675","title":"Liminatus Pharma prices 13.8M shares at 29c in public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612450675","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612450675?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:55","pubTimestamp":1771336530,"startTime":"0","endTime":"0","summary":"Liminatus Pharma (LIMN) announced the pricing of its best-efforts public offering of 13,813,000 shares of its common stock and warrants to purchase...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-prices-13-8m-shares-at-29c-in-public-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-prices-13-8m-shares-at-29c-in-public-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612457725","title":"Liminatus Pharma Announces $4 Million Public Offering With Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2612457725","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612457725?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:44","pubTimestamp":1771335858,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. has announced the pricing of a public offering, including 13,813,000 shares of common stock and warrants to purchase up to 20,719,500 shares at an exercise price of $0.29 per share. The warrants are immediately exercisable and will expire five years from the issuance date. The offering is expected to raise approximately $4.0 million, with potential additional proceeds of $6.0 million if all warrants are exercised.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL8ch9B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BKPKM429.USD","LU0314104364.USD","LU2210149790.SGD","LIMN","NDAQ","BK4588","BK4585","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","BK4139","LU2210150020.SGD","IE00BGHQF748.EUR","BK4112","SG9999014039.USD","SG9999014013.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612715457","title":"Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612715457","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612715457?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:44","pubTimestamp":1771335840,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUA15WLJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612457713","title":"Liminatus Pharma Inc - Offering Price Set at $0.29 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2612457713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612457713?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:44","pubTimestamp":1771335840,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUA15WLJW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610962744","title":"Iris Acquisition Corp. II Files Initial Statement of Beneficial Ownership; Manish C. Shah Listed as Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2610962744","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610962744?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:42","pubTimestamp":1770849732,"startTime":"0","endTime":"0","summary":"Iris Acquisition Corp. II has filed an initial statement of beneficial ownership with the SEC. The filing lists Manish C. Shah as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iris Acquisition Corp. II published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL4R4cr2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Iris Acquisition Corp. II Files Initial Statement of Beneficial Ownership; Manish C. Shah Listed as Director","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610671923","title":"Iris Acquisition Corp. II Announces Publication of Unqualified Independent Audit Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2610671923","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610671923?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:46","pubTimestamp":1770759972,"startTime":"0","endTime":"0","summary":"Iris Acquisition Corp. II has announced the release of its independent audit report. The report covers the financial statements as of February 4, 2026, and is an unqualified opinion issued by KNAV CPA LLP. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iris Acquisition Corp. II published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDLb56YC9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610664690","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2610664690","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610664690?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:38","pubTimestamp":1770676680,"startTime":"0","endTime":"0","summary":"Defiance Dly Tgt 2x Lg      MSTX   125,609,665      2.67     0.13      5.12. Defiance Tgt 2X Lg HIMS     HIMZ   100,899,750      1.81    -0.90    -33.21. GrShr 2x Sh NVDA Daily       NVD    77,057,549      6.65    -0.34     -4.86. iShares Bitcoin Trust ETF   IBIT    76,840,616     40.11     0.43      1.08. ProShares UltraPro QQQ      TQQQ    70,320,465     51.74     1.15      2.27. Direxion Dly TSLA Br 1X     TSLS    64,125,429      5.43    -0.08     -1.45. Direxion TSLA Bull 2X       TSLL    60,460,305     15.97     0.47      3.03. Invesco QQQ Trust I          QQQ    55,874,071    614.32     4.67      0.77. Direxion Dly PLTR Bear 1X   PLTD    45,441,943      7.92    -0.43     -5.15","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","LU2360032135.SGD","IE00BQXX3D17.EUR","LU1037948897.HKD","IE00B5949003.HKD","LU1244550221.USD","GB00BDT5M118.USD","IE00BKVL7J92.USD","LU2764262908.HKD","LU0323591593.USD","LU2931357623.SGD","IE00B3SWFQ91.USD","PLTY","LU2023250330.USD","SG9999015945.SGD","LU1084165304.USD","IE00BKDWB100.SGD","LU2322448791.USD","PLYY","SG9999013486.USD","LU2250418816.HKD","LU2404859741.USD","LU2361044865.SGD","LU0950375773.USD","LU0107464264.USD","LU0965508806.USD","IE00BK4W5M84.HKD","TSLT","LU1712237335.SGD","LU0868494708.USD","BK4605","SNVD.UK","LU0345769128.USD","LU0957808578.USD","NVIW.SI","LU1914381329.SGD","BK4515","LU0965509101.SGD","LU2097344431.USD","BK4023","BK4614","LU0171293334.USD","LU0348723411.USD","LU2506951958.HKD","LU2720916845.USD","BK4503","LU0879622024.SGD","IREN","LU0289961442.SGD","LU2065170008.USD","LU1992135472.HKD","LU2471134952.CNY","TSLL","LU2746668974.SGD","IE0034235303.USD","HK0000306701.USD","LU0316494557.USD","LU0738911758.USD","LU2097829019.USD","BK4612","LU0472753341.HKD","LU0532188223.SGD","LU1585245621.USD","NDX","PLTA","LU2023250504.SGD","LU2458330169.SGD","MSFO","LU0069063385.USD","LU1861127337.USD","LU0823417737.USD","LU2089284900.SGD","LU1551013425.SGD","LU0256863902.USD","SG9999001424.SGD","IE0004091025.USD","NVDU","LU0642271901.SGD","LU1564329115.USD","LU2552382215.SGD","LU0095938881.EUR","LU2168564149.EUR","LU0724617625.USD","LU0048584097.USD","GB00B4QBRK32.GBP","LU2265009873.SGD","IE00BK4W5L77.USD","BK4585","LU2125909759.SGD","SG9999013478.USD","LU0889565833.HKD","3NVD.UK","LU0070217475.USD","LU0957791311.USD","LU0053666078.USD","LU0823414551.USD","BK4548","IE00BJJMRX11.SGD","LU1861215975.USD","IE00B19Z8X17.USD","LU2125909916.SGD","LU0784383803.USD","LU2108987350.USD","TSLG","IBIT","LU0726765562.USD","INTC","PLTR","LU0238689110.USD","LU0081259029.USD","BK4533","IE0001KFT4U8.USD","LU2860962120.EUR","LU1119994496.HKD","IE00BBT3K403.USD","LU0417517546.SGD","LU0345768153.USD","LU0683600562.USD","LU1340139317.AUD","LU0321505439.SGD","LU1066051225.USD","BK4567","LU0820562030.AUD","BK4574","LU2362540622.SGD","IE00BQXX3F31.USD","TSLP","LU1935043536.SGD","LU0061474705.USD","LU2506951792.HKD","LU1670710661.SGD",".IXIC","LU1074936037.SGD","LU2242650005.HKD","LU1232071149.USD","IE00BN29S564.USD","LU1674673691.USD","LU1720051108.HKD","LU1778281490.HKD","LU0353189763.USD","BK4577","HK0000914660.USD","LU0345769631.USD","LU1989773731.SGD","LU1035773651.USD","LU2111349929.HKD","TSLQ","LU2430703251.USD","LU1267930490.SGD","LU0210536198.USD","BK4550","LU1066051811.HKD","LU2404859667.USD","LU2491050154.USD","IE0034235295.USD","LU2420271590.USD","LU0265550946.USD","LU2360106780.USD","LU2237957902.USD","LU0162691827.USD","LU1839390173.USD","LU2168564065.EUR","IE00B775SV38.USD","LU0109392836.USD","LU0310800379.SGD","BK4592","LU2271345857.HKD","LU1366333091.USD","LU2237443549.SGD","LU1861558580.USD","BK4099","LU1623119135.USD","IE00BKPKM429.USD","HK0000320264.USD","LU0354030438.USD","LU1430594728.SGD","LU1670628061.USD","LU0345774631.USD","NVDW","NVDY","LU2381873111.SGD","LU0960925559.SGD","LU0323239441.USD","TSLR","LU0198837287.USD","LU1852331112.SGD","LU2168564495.EUR","LU1064131342.USD","LU0094547139.USD","LU2247934214.USD","IE00B19Z8W00.USD","BK4593","LU0690374615.EUR","LU0979878070.USD","IE00B5TLWC47.USD","04335","LU0441851309.USD","LU1121112475.USD","SG9999002604.SGD","TSLO","IE0004445015.USD","LU1032466523.USD","IE000W1ABFV2.USD","IE00B4JS1V06.HKD","LU2357125470.USD","IE00BN8TJ469.HKD","BK4527","LU1261432733.SGD","PLTD","SGXZ51526630.SGD","LU2417539215.USD","NVDS","LU1564329628.SGD","LU0106261372.USD","SG9999006266.SGD","LU0314106906.USD","LU2505996509.AUD","GRAB","NVDD","LU1496350502.SGD","LU2083900584.USD","LU2236285917.USD","LU2237443382.USD","SGXZ58947870.SGD","BK4512","LU1181866309.USD","BK4602","LU1366192091.USD","LU1435385759.SGD","LU2045819591.USD","LU1069347547.HKD","LU2750360997.AUD","IE00BHPRN162.USD","LU0868494617.USD","IE00BZ9MQY76.HKD","LU1868837300.USD","LU2065169927.USD","LU2746668461.USD","LU0158827948.USD","HIMZ","IE00BJJMRY28.SGD","LU0312595415.SGD","LU1564329461.SGD","LU2602419157.SGD","LU0689626769.HKD","IE00B1BXHZ80.USD","LU0757359368.USD","SGXZ81514606.USD","LU2896262040.SGD","BK4534","LU1934455277.USD","LU0109391861.USD","LU0871640123.AUD","LU0640476718.USD","LU2552382132.HKD","LU1699723380.USD","IE00B3M56506.USD","TESL","LU1032955483.USD","PLTZ","IE00BSNM7G36.USD","LU0345774391.USD","LU2148611432.USD","MSFU","LU1988902786.USD","NVDG","IE0004086264.USD","LU0345768740.USD","LU0314104364.USD","MSFW","LU1935042215.USD","LU1334329650.SGD","LU1974910355.USD","IE00B1XK9C88.USD","QQQ","LU0889566641.SGD","SG9999015952.SGD","LU0308772762.SGD","IE00BDRTCR15.USD","LU0077335932.USD","LU1923622291.USD","LU1983260115.SGD","NVD2.UK","LU1917777945.USD","MSFD","LU1280957306.USD","LU1043141123.HKD","BK4022","SG9999002414.USD","LU0942090050.USD","BK4538","IE0034235188.USD","LU1642822529.SGD","LU2065171311.SGD","LU2290526834.HKD","NVDS.UK","LU0187121727.USD","LU2360107168.USD","PLT","LU1935043023.USD","BK4516","BK4601","LU2089283258.USD","LU1951198990.SGD","LU2347655156.SGD","LU2764263203.CNY","LU1069344957.HKD","LU2089985449.USD","LU0345770308.USD","IE00BJTD4V19.USD","IE00BJLML261.HKD","LU0234570918.USD","LU1571399168.USD","LU1989772923.USD","LU0124676726.USD","LU0557290698.USD","LU1992135399.USD","LU1221951129.SGD","LU1935042488.USD","LU0072462426.USD","SG9999018857.SGD","LU1674673428.USD","LU0215105999.USD","IE00BD6J9T35.USD","TSII","TQQQ","LU0210533765.USD","LU0210637038.USD","LU0347712357.USD","LU0444971666.USD","IE000KEQY171.SGD","LU2750360641.GBP","LU0823434740.USD","LU2210150020.SGD","PLTG","LU0056508442.USD","LU2023251221.USD","IE00BYQQ9H92.USD","LU0061475181.USD","LU0965509010.AUD","CRSH","LU1127390331.HKD","LU1697837992.HKD","LU2237443622.USD","LU0011850046.USD","LU2471134523.USD","LU0097036916.USD","TSLY","LU0994945656.USD","LU1267930813.SGD","MSTX","LU0345770993.USD","LU1244550577.SGD","LU1989764664.SGD","LU0784385170.HKD","IE00BMPRXR70.SGD","LU1066051498.USD","LU2087625088.SGD","LU2592432038.USD","LU2077746001.SGD","LU0096364046.USD","LU1582987597.SGD","LU0784384876.USD","BK4554","IE00BZ199S13.USD","IE00BZ1G4Q59.USD","BITF","SG9999015978.USD","LU2092627202.USD","LU1804176565.USD","IE00BMPRXQ63.HKD","BK4141","LU0225283273.USD","BK4504","LU2362541273.HKD","LU0061474960.USD","SG9999002224.SGD","LU2756315664.SGD","SG9999015358.SGD","BK4532","LU1548497426.USD","LU0494093205.USD","LU1791710400.SGD","PLTW","IE00B19Z9505.USD","LU2456880835.USD","IE0005OL40V9.USD","LU1821325948.USD","LU0289739343.SGD","LU2092937148.SGD","2NVD.UK","LU0823421333.USD","LU2106854487.HKD","LU1003077747.HKD","SG9999015341.SGD","LU2430703178.SGD","IE000YTNTUN2.SGD","LU1721428933.USD","LU0289960550.SGD","BK4535","LU0353189680.USD","LU0823414478.USD","LU2237443465.HKD","LU0211327993.USD","BK4594","LU0170899867.USD","LU1153585028.USD","LU0708995401.HKD","IE0003U64NQ7.SGD","LU0823411888.USD","LU2097344357.USD","TSYY","LU2362541513.USD","LU0661504455.SGD","LU0426412945.USD","MSTR","IE00BJTD4N35.SGD","LU2092937221.SGD","LU0072461881.USD","LU0175139822.USD","LU1582986433.USD","SG9999002232.USD","BK4511","IE00BDCRKT87.USD","LU2272731782.SGD","LU0057025933.USD","NVDA","IE00BFSS8Q28.SGD","BK4579","LU0029864427.USD","BK4561","LU0154236417.USD","LU2403377893.USD","LU2506952097.USD","BK4613","IE0009G5SDU7.USD","TSDD","LU2505996681.GBP","LU1496350171.SGD","SG9999001077.SGD","LU2125154935.USD","LU1506573853.SGD","BK4588","LU0210528500.USD","LU2471134796.USD","TSLZ","SG9999014906.USD","AMZN","SG9999014575.USD","LU2125154778.USD","LU2298321311.HKD","LU1037948541.HKD","LU0302445910.USD","LU2326559502.SGD","LU0276348264.USD","BK4547","LU1316542783.SGD","LU2433249047.HKD","SG9999014914.USD","IE00B7KXQ091.USD","LU1035775433.USD","LU2133065610.SGD","LU1301847155.USD","BK4097","LU2264538146.SGD","LU1242518857.USD","LU0795875086.SGD","SG9999002620.SGD","IE00B775H168.HKD","LU1691799644.USD","LU1923622614.USD","LU1934455194.USD","LU2322448957.HKD","LU2764263039.SGD","SG9999013460.SGD","LU0320765059.SGD","LU1221951046.USD","LU1236620834.HKD","NVDX","LU1116320737.USD","LU2471134879.HKD","LU2213496289.HKD","LU2244417387.USD","LU2360108059.USD","LU2168564222.USD","LU1815333072.USD","LU2347655073.USD","BK4528","IE00BFSS7M15.SGD","LU0456855351.SGD","LU1823568750.SGD","LU0943347566.SGD","LU0912757837.SGD","TSLW","LU1868837136.USD","LU1951200564.SGD","LU2237957811.SGD","LU1989763005.USD","LU0757359954.USD","LU0128525929.USD","NVII","LU2463028550.USD","LU0251132253.USD","LU2413666699.HKD","BK4549","LU0390134368.USD","LU0792757196.USD","LU1196500208.SGD","LU0310799852.SGD","BK4555","LU1935042991.SGD","LU0985320562.USD","LU0786609619.USD","IE000ITXATA3.USD","LU0894486033.HKD","LU1116320901.HKD","IE00BLSP4239.USD","LIMN","BK4525","LU0511384066.AUD","LU0787776722.HKD","LU1923623000.USD","LU2028103732.USD","NVD","IE0009356076.USD","BK4581","LU0289941410.SGD","LU2458330243.SGD","LU2506951875.HKD","LU1043141396.HKD","PLTU","LU2065171402.SGD","DIPS","LU1059921491.USD","SG9999018865.SGD","SGXZ23171101.USD","LU2487616109.SGD","BK4575","LU2357305700.SGD","IE00B19Z9P08.USD","LU1236620750.USD","LU0689472784.USD","LU0127658192.USD","LU1046421795.USD","LU2041044095.USD","LU2430703095.HKD","MSFX","LU2491049909.HKD","LU2756315318.SGD","LU2294711713.HKD","BK4543","LU0784385840.USD","LU2462157665.USD","LU1242518931.SGD","LU1720051017.SGD","LU1791710582.SGD","HK0000306685.HKD","LU0006306889.USD","LU2242649171.HKD","LU1066053197.SGD","MSFY","BK4529","IE00B19Z9Z06.USD","LU0965509283.SGD","IE00BMPRXN33.USD","LU1323610961.USD","SG9999004303.SGD","LU1861559042.SGD","LU0466842654.USD","LU2286300806.USD","LU0267386448.USD","LU0211328371.USD","IE00BFXG0V08.USD","LU1732799900.SGD","LU1815336760.USD","IE00BYXW3230.USD","LU2125909593.SGD","LU0949170772.SGD","LU0082616367.USD","LU2272731600.USD","LU0823421416.USD","LU1861220033.SGD","LU0964807845.USD","LU0949170426.SGD","IE0004445239.USD","LU1429558221.USD","LU1989772840.SGD","LU0476273544.USD","IE00BQXX3C00.GBP","IE00BLSP4452.SGD","LU0203201768.USD","SG9999015986.USD","LU1934455863.HKD","LU1188199696.SGD","LU2210149790.SGD","BK4587","LU2275660780.HKD","LU2237443895.HKD","LU1718418525.SGD","BK4608","LU0274383776.USD","LU0823417653.USD","PLOO","NVDL","LU1235294995.USD","LU2552382058.USD","LU0080751232.USD","LU0823434583.USD","SG9999014542.SGD","LU0265550359.USD","LU2272731865.HKD","LU2452424414.USD","SG9999014567.USD","IE00B894F039.SGD","LU1629891620.HKD","HK0000320223.HKD","LU2063271972.USD","LU1235295455.SGD","SG9999014898.SGD","MSFT","TSLI","LU0158827781.USD","LU1839511570.USD","LU2095319765.USD","MSFL","NVD3.UK","NVDQ","LU1228905037.USD","SGXZ99366536.SGD","BK4598","LU2506952170.USD","LU0719512351.SGD","BTC.USD.CC","LU1868836914.USD","LU2543165471.USD","LU1244550494.USD","TSLS","BK4551","LU1814569148.SGD","LU1551013342.USD","SGXZ31699556.SGD","QQQI","LU2125910500.SGD","LU0256863811.USD","LU0545562505.USD","LU1803068623.USD","LU2361045086.USD","07766","LU1670627923.USD","SG9999017495.SGD","LU0545039389.USD","LU1670710588.SGD","BK4604","LU1989764748.USD","LU0820561909.HKD","LU0149725797.USD","LU2237443978.SGD","BK4230","SG9999014880.SGD","SG9999002406.SGD","LU1732800096.USD","BK4576","LU2023250843.SGD","LU1228905540.USD","LU1582987324.SGD","LU0820561818.USD","LU1267930730.SGD","LU2168563687.JPY","BK4122","LU2087621335.USD","LU0321505868.SGD","LU2491050071.SGD","HK0000914686.HKD","LU1145028129.USD","SG9999014559.SGD","LU2473716301.USD","SOFI","LU0266013472.USD","LU0203202063.USD","LU0882574139.USD","LU1670711123.USD","LU2237438978.USD","TSL","IE00B3S45H60.SGD","LU0528227936.USD","LU1868836591.USD","LU2054465674.USD","IE00BWXC8680.SGD","SG9999001135.SGD","SG9999002679.SGD","SG9999000418.SGD","LU0426417589.USD","LU1564329032.USD","LU0234572021.USD","GB00B4LPDJ14.GBP","LU2249611893.SGD","LU0444973449.USD","LU0079474960.USD","LU0096362180.USD","LU0894485498.HKD","LU2191332357.HKD","IE00B4YYXB79.USD","LU2125909247.SGD","LU0861579265.USD","LU1670711040.USD","BK4566","LU0323240290.USD","TSLA","LU2361044949.HKD","LU2279689827.SGD","LU2461242641.AUD","LU1267930573.SGD","PTIR","LU0672654240.SGD","LU1868836757.USD","LU1582986359.USD","LU0157215616.USD","LU2413666426.HKD","LU1803068979.SGD","LU0354030511.USD","LU1633808545.USD","LU0690374961.EUR","LU0342679015.USD","LU2211815571.USD","LU0708994859.HKD","LU0795875169.SGD","LU0788109477.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610265663","title":"BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2610265663","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610265663?lang=en_us&edition=fundamental","pubTime":"2026-02-10 04:06","pubTimestamp":1770667567,"startTime":"0","endTime":"0","summary":"BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLCFeb 9  - Liminatus Pharma Inc LIMN.O:LIMINATUS PHARMA INC - ON FEB 6, CO ENTERS SETTLEMENT AGREEMENT WITH CLEAR STREET LLC - SEC FILINGLIMINATUS PHARMA INC - TO ISSUE 4 MILLION SHARES OF COMMON STOCK TO HOLDER IN EXCHANGE FOR SURRENDER AND CANCELLATION OF 805,377 WARRANTS ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610663473","title":"Liminatus Pharma Inc - to Issue 4 Mln Shares of Common Stock to Holder in Exchange for Surrender and Cancellation of 805,377 Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2610663473","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610663473?lang=en_us&edition=fundamental","pubTime":"2026-02-10 04:03","pubTimestamp":1770667430,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50RG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610266344","title":"Liminatus Pharma Inc - on Feb 6, Co Enters Settlement Agreement With Clear Street Llc - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2610266344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610266344?lang=en_us&edition=fundamental","pubTime":"2026-02-10 04:03","pubTimestamp":1770667430,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610663416","title":"Liminatus Pharma Issues 4 Million Unregistered Shares to Settle Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2610663416","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610663416?lang=en_us&edition=fundamental","pubTime":"2026-02-10 04:02","pubTimestamp":1770667341,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. has announced the unregistered issuance of 4,000,000 shares of its common stock to Clear Street LLC. The shares were issued in exchange for the surrender and cancellation of 805,377 warrants previously held by Clear Street LLC. This transaction was conducted without the payment of any commission or other remuneration and relied on the exemption from registration provided by Section 3 of the Securities Act of 1933. The agreement also includes the dismissal of pending litigation between the two parties.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL2Pq9fl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609538567","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2609538567","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609538567?lang=en_us&edition=fundamental","pubTime":"2026-02-06 06:42","pubTimestamp":1770331320,"startTime":"0","endTime":"0","summary":"iShares Bitcoin Trust ETF   IBIT   271,172,990     36.10    -5.47    -13.16. Strive Cl A                 ASST   169,453,033    0.4931    -0.10    -16.76. ProShares UltraPro QQQ      TQQQ   154,528,162     47.64    -2.12     -4.26. Defiance Dly Tgt 2x Lg      MSTX   115,968,771      1.67    -0.88    -34.51. iShares Ethereum Tr ETF     ETHA   107,619,284     14.06    -2.28    -13.95. Direxion Dly TSLA Br 1X     TSLS    97,408,795      5.71     0.13      2.33. Alphabet Cl A              GOOGL    87,629,661    331.25    -1.79     -0.54. Invesco QQQ Trust I          QQQ    87,485,524    597.03    -8.72     -1.44. Direxion TSLA Bull 2X       TSLL    87,198,505     14.50    -0.67     -4.42. ProSh UltraPro Shrt QQQ     SQQQ    78,143,504     74.58     3.09      4.32","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","IE00BWXC8680.SGD","LU0477156953.USD","LU2168563687.JPY","LU0823421333.USD","SG9999013478.USD","TSLI","LU0943347566.SGD","LU0994945656.USD","LU1242518857.USD","LU2750360997.AUD","GB00B4QBRK32.GBP","BK4532","PLTG","IE0001KFT4U8.USD","LU2089283258.USD","BK4555","GGLS","LU0130517989.USD","LU0784385840.USD","PLTZ","LU2092937148.SGD","LU2249611893.SGD","LU0314104364.USD","PLTY","LU0690374615.EUR","SG9999014906.USD","LU0310800965.SGD","BK4535","LU0097036916.USD","LU0823414478.USD","LU1261432733.SGD","LU1323610961.USD","LU2236285917.USD","LU0553294199.USD","LU1235294995.USD","SG9999015978.USD","LU0029864427.USD","LU1585245621.USD","LU0048573561.USD","LU0080751232.USD","TSLT","LU0784385170.HKD","LU1066051225.USD","IE0034235188.USD","IE0004091025.USD","LU1823568750.SGD","LU0198837287.USD","SGXZ51526630.SGD","LU2505996681.GBP","BK4122","SGXZ31699556.SGD","LU0006306889.USD","LU1244550221.USD","LU0127658192.USD","BK4604","LU2168564065.EUR","SG9999014914.USD","BK4593","LU0719512351.SGD","LU0081259029.USD","SGXZ81514606.USD","LU0820562030.AUD","IE0004086264.USD","LU1267930573.SGD","SG9999000418.SGD","GB00B4LPDJ14.GBP","LU1571399168.USD","LU2430703095.HKD","LU0784383803.USD","LU2420271590.USD","LU0648001328.SGD","IE00BKPKM429.USD","BK4023","LU0310800379.SGD","BK4592","LU0061474705.USD","PLT","LU2491050071.SGD","ETHA","SG9999014880.SGD","GOOY","07766","BK4514","IE00BK4W5L77.USD","IE00B19Z8X17.USD","LU2168564222.USD","LU1506573853.SGD","LU2089985449.USD","LU0077335932.USD","LU0251142724.SGD","LU1988902786.USD","LU1066051498.USD","LU0310799852.SGD","LU0889566641.SGD","LU0466842654.USD","PTIR","IE00BQXX3D17.EUR","LU0980610538.SGD","LU2462157665.USD",".IXIC","BK4516","LU2077746001.SGD","LU2023250843.SGD","LU0289960550.SGD","SG9999006266.SGD","LU0949170426.SGD","LU0979878070.USD","LU1316542783.SGD","LU2168564149.EUR","SG9999001135.SGD","ETH.USD.HKCC","LU0690374961.EUR","IE00BJTD4V19.USD","BK4561","TESL","IE00BKDWB100.SGD","LU0210533765.USD","LU0211326755.USD","LU0792757196.USD","TSLW","IE00BJTD4N35.SGD","LU1064131342.USD","LU0882574139.USD","BK4529","LU0203345920.USD","TSLP","LU2054465674.USD","SG9999015945.SGD","LU2125154935.USD","LU1839390173.USD","LU2065170008.USD","BK4550","IE00B19Z3B42.SGD","LU2271345857.HKD","LU0345768153.USD","LU0234570918.USD","LU2097344431.USD","BK4585","LU2237438978.USD","LU2471134796.USD","LU1435385759.SGD","LU1059921491.USD","LU0225283273.USD","LU2087625088.SGD","LU2023250330.USD","BK4554","LU1674673691.USD","LU2746668461.USD","LU0348723411.USD","LU0353189680.USD","IE00BZ9MQY76.HKD","LU2491050154.USD","PLOO","BTC.USD.CC","TSDD","LU0426417589.USD","LU2028103732.USD","LU2403377893.USD","04335","LU2106854487.HKD","LU0109391861.USD","TSL","LU0661504455.SGD","LU2213496289.HKD","LU0096362180.USD","LU0742534661.SGD","LU1116320737.USD","LU0354030511.USD","SG9999017495.SGD","IE00B19Z3581.USD","IE00BHPRN162.USD","LU0265550359.USD","LU1046421795.USD","LU0256863902.USD","BK4099","PLTW","TEAD","QQQI","NVDA","LU1221951129.SGD","LU0107464264.USD","LU1878469433.USD","LU0130103400.USD","LU0157215616.USD","LU2242649171.HKD","IE00BMPRXR70.SGD","LU1267930730.SGD","LU2404859741.USD","LU1989764664.SGD","LU1778281490.HKD","LU2168564495.EUR","LU0444973449.USD","IE00B1XK9C88.USD","LU1935042991.SGD","LU0528227936.USD","LU0496365809.HKD","BK4598","LU1935042488.USD","LU2360106780.USD","LU0154236417.USD","BK4566","LU2471134879.HKD","LU1301847155.USD","LU0648000940.SGD","LU1551013342.USD","PLTD","LU0957791311.USD","IE00BLSP4452.SGD","LU1894683348.USD","LU1935042215.USD","LU2357305700.SGD","SG9999002620.SGD","IE00BSNM7G36.USD","IE0034235303.USD","LU0070217475.USD","LU2092627202.USD","LU0823411888.USD","LU1868837136.USD","INTC","LU2362541513.USD","LU2242650005.HKD","IE00B19Z9Z06.USD","LU0672654240.SGD","LU2404859667.USD","LU0130518102.USD","SGXZ99366536.SGD","LU1868836757.USD","LU0868494708.USD","LU0738911758.USD","LU0345770993.USD","LU0320765489.SGD","LU0320765059.SGD","LU0061474960.USD","IE00BLSP4239.USD","LU1429558221.USD","LU1548497426.USD","LU1145028129.USD","LU1951200564.SGD","LU0957808578.USD","LU1003077747.HKD","IE00BN8TJ469.HKD","LU0170899867.USD","LU1815336760.USD","LU1066053197.SGD","LU1267930813.SGD","BK4512","BK4551","LU1852331112.SGD","LU2290526834.HKD","LU0345769128.USD","SG9999013486.USD","BK4511","BK4576","LU2360107168.USD","LU0683600562.USD","TSII","LU1935043536.SGD","LU2244417387.USD","LU0314106906.USD","LU2456880835.USD","LU0056508442.USD","LU1633808545.USD","LU2275660780.HKD","LU0158827781.USD","LU1496350171.SGD","LU2097344357.USD","PLTA","SG9999013460.SGD","LU1642822529.SGD","LU2111349929.HKD","LU1718418525.SGD","LU0426412945.USD","LU2065171402.SGD","LU1267930490.SGD","BK4602","LU0130102774.USD","LU2592432038.USD","BK4548","LU2430703251.USD","SG9999018865.SGD","LU1430594728.SGD","LU0070302665.USD","LU1670627923.USD","IE00BMPRXQ63.HKD","LU0708994859.HKD","LU0642271901.SGD","LU0158827948.USD","LU0345774391.USD","LU0234572021.USD","LU1496350502.SGD","IE00BKVL7J92.USD","SG9999002679.SGD","LU0265550946.USD","LU0689472784.USD","LU1720051017.SGD","LU1861220033.SGD","TSLL","LU1221951046.USD","LU1674673428.USD","BK4575","LU2750360641.GBP","LU1803068623.USD","IE00BQXX3C00.GBP","LU0321505868.SGD","LU0868494617.USD","LU1720051108.HKD","SG9999002604.SGD","LU1868836591.USD","LU0345770308.USD","LU1868837300.USD","LU2543165471.USD","LU1989764748.USD","BK4077","LU1629891620.HKD","BK4141","LU0210536198.USD","LU0787776722.HKD","IE00B19Z8W00.USD","LU0274383776.USD","LU0128525929.USD","LU0187121727.USD","LU0251132253.USD","LU1043141396.HKD","LU1032955483.USD","PTON","LU1121112475.USD","LU2265009873.SGD","LU0964807845.USD","LU0149725797.USD","SGXZ58947870.SGD","SG9999015986.USD","LU0106261372.USD","IE00BK4W5M84.HKD","LU2125154778.USD","TSLQ","IE00B19Z9505.USD","IE00BBT3K403.USD","LU0476273544.USD","LU1232071149.USD","BK4612","IE00B1BXHZ80.USD","IE00BMPRXN33.USD","LU0256863811.USD","LU0708995401.HKD","SG9999002414.USD","GOU","LU0321505439.SGD","SG9999018857.SGD","LU1804176565.USD","LU1839511570.USD","LU0302445910.USD","BK4581","BK4543","LU2756315664.SGD","BK4538","LU1366192091.USD","LU1880398554.USD","LU1894683264.USD","LU0441851309.USD","LU1084165304.USD","LU1366333091.USD","IBIT","LU0276348264.USD","BK4022","SG9999014898.SGD","BK4190","LU1242518931.SGD","TSLG","IE00BJLML261.HKD","LU2125910500.SGD","PLYY","IE00BQXX3F31.USD","TSYY","LU1861215975.USD","BK4601","BK4515","LU1974910355.USD","SG9999015952.SGD","LU1280957306.USD","LU2860962120.EUR","LU0011850046.USD","IE00BFMHRM44.USD","LU0052756011.USD","LU2362541273.HKD","TSLR","LU0128525689.USD","LU2065169927.USD","LU1917777945.USD","LU1880398471.USD","LU0267386448.USD","BK4527","BK4588","LU0210637038.USD","LU0820561909.HKD","TSLZ","LU2264538146.SGD","LU1670628061.USD","SQQQ","LU1791710582.SGD","LU0444971666.USD","LU2089284900.SGD","LU0976567544.SGD","LU1043141123.HKD","LU2063271972.USD","LU2896262040.SGD","LU0545039389.USD","LU2417539215.USD","LU1201861249.SGD","LU0557290698.USD","BK4503","LU1196500208.SGD","LU2108987350.USD","LU2191332357.HKD","LU1861559042.SGD","LU2756315318.SGD","TSLO","LU0417517546.SGD","LU2602419157.SGD","LU2362540622.SGD","LU0211327993.USD","LU0354030438.USD","LU1868836914.USD","CRSH","LU1951198990.SGD","LU0203347892.USD","LU0784384876.USD","IE00BZ1G4Q59.USD","TSLS","ASST","LU1244550577.SGD","LU0942090050.USD","BK4579","LU2087621335.USD","TSLY","LU0211328371.USD","LU1303367103.USD","LU2381873111.SGD","IE00B19Z9P08.USD","LU2211815571.USD","LU0823421416.USD","LU2326559502.SGD","LU0208291251.USD","LU1914381329.SGD","GOOX","LU0640476718.USD","LU2148611432.USD","BK4534","LU0175139822.USD","LIMN","LU2247934214.USD","LU1153585028.USD","LU0053666078.USD","LU0211331839.USD","LU2746668974.SGD","LU0211326839.USD","ETH.USD.CC","LU2023251221.USD","LU0342679015.USD","LU0215105999.USD","BK4605","BK4573","LU0494093205.USD","LU0061475181.USD","LU1119994496.HKD","IE0002270589.USD","LU1815333072.USD","LU0345769631.USD","GOOP","LU0094547139.USD","SG9999002406.SGD","LU0949170772.SGD","LU2491049909.HKD","LU1699723380.USD","LU2045819591.USD","LU1116320901.HKD","LU2430703178.SGD","LU2471134523.USD","LU0532188223.SGD","LU0477156797.USD","LU0345774631.USD","LU1861558580.USD","BK4533","LU0048584097.USD","LU1551013425.SGD","LU2931357623.SGD","GOOW","BK4594","LU0820561818.USD","LU2065171311.SGD","LU2023250504.SGD","LU0312595415.SGD","LU1791710400.SGD","LU0353189763.USD","LU1935043023.USD","LU2098885051.SGD","LU0345768740.USD","TQQQ","LU0082616367.USD","PLTU","LU2360032135.SGD","LU1066051811.HKD","MSTX","LU0323591593.USD","LU2505996509.AUD","IE00B894F039.SGD","LU0823434740.USD","LU1923623000.USD","LU0985320562.USD","BK4613","LU0316494557.USD","BK4230","LU0251131958.USD","LU1267930227.SGD","LU1244550494.USD","IE00B7SZLL34.SGD","LU0823434583.USD","LU2250418816.HKD","LU2097829019.USD","LU1201861165.SGD","LU0096364046.USD","BK4574","LU2471134952.CNY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2609394144","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:08 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2609394144","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609394144?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:08","pubTimestamp":1770228492,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:08 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nAQN2LKQEY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606890229","title":"Liminatus Pharma Faces Nasdaq Delisting Risk Over Sub-$1 Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2606890229","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606890229?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:31","pubTimestamp":1769463113,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. has received a notice from the Nasdaq Listing Qualifications Department indicating that the company is no longer in compliance with the Nasdaq Listing Rule 5450, which requires listed securities to maintain a minimum bid price of $1 per share. The company’s common stock has closed below this threshold for 30 consecutive business days. Liminatus has been given 180 calendar days, until July 14, 2026, to regain compliance, which can be achieved if the closing bid price meets or exceeds $1 for at least ten consecutive business days. If necessary, the company may implement a reverse stock split to meet the requirement. Failure to regain compliance could result in delisting from Nasdaq, though additional time to comply may be available.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL7lBT3x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586785404","title":"Liminatus Pharma Faces Nasdaq Delisting Over Market Value Rule Breach","url":"https://stock-news.laohu8.com/highlight/detail?id=2586785404","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586785404?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:27","pubTimestamp":1764109648,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. has received notices from the Nasdaq Listing Qualifications Department indicating non-compliance with several Nasdaq listing rules. The company failed to maintain a minimum Market Value of Listed Securities of $50 million and a minimum Market Value of Publicly Held Shares of $15 million over the past 30 consecutive business days. Additionally, Liminatus does not meet requirements for total assets and revenue under another Nasdaq rule. Although these notifications do not immediately affect the company's stock listing, Liminatus is at risk of delisting if it cannot regain compliance within the prescribed timeframe. The company is actively working to address these deficiencies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL7LLTmk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579312388","title":"Liminatus Pharma, Inc. (Nasdaq: Limn) Signs Mou With Capital Trust Group for USD 30 Million Equity Investment via an Earn-Out Mechanism and Future Strategic Cooperation","url":"https://stock-news.laohu8.com/highlight/detail?id=2579312388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579312388?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:04","pubTimestamp":1761833069,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUA4CJZHK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0823},{"period":"1month","weight":0.0234},{"period":"3month","weight":-0.5106},{"period":"6month","weight":-0.828},{"period":"1year","weight":-0.9717},{"period":"ytd","weight":-0.6984}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0773},{"period":"3month","weight":0.0974},{"period":"6month","weight":0.1135},{"period":"1year","weight":0.2733},{"period":"ytd","weight":0.0972}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Iris Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. The company was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp is a subsidiary of Iris Acquisition Holdings LLC.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.012085},{"month":2,"riseRate":0.8,"avgChangeRate":-0.095795},{"month":3,"riseRate":0.4,"avgChangeRate":-0.116654},{"month":4,"riseRate":0.6,"avgChangeRate":-0.021172},{"month":5,"riseRate":0.2,"avgChangeRate":-0.021158},{"month":6,"riseRate":0.6,"avgChangeRate":0.20484},{"month":7,"riseRate":0.4,"avgChangeRate":-0.094814},{"month":8,"riseRate":0.2,"avgChangeRate":-0.116647},{"month":9,"riseRate":0.6,"avgChangeRate":-0.070493},{"month":10,"riseRate":0.6,"avgChangeRate":-0.032984},{"month":11,"riseRate":0.4,"avgChangeRate":-0.052841},{"month":12,"riseRate":0.6,"avgChangeRate":-0.075377}],"exchange":"NASDAQ","name":"Liminatus Pharma LLC","nameEN":"Liminatus Pharma LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liminatus Pharma LLC(LIMN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liminatus Pharma LLC(LIMN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liminatus Pharma LLC,LIMN,Liminatus Pharma LLC股票,Liminatus Pharma LLC股票老虎,Liminatus Pharma LLC股票老虎国际,Liminatus Pharma LLC行情,Liminatus Pharma LLC股票行情,Liminatus Pharma LLC股价,Liminatus Pharma LLC股市,Liminatus Pharma LLC股票价格,Liminatus Pharma LLC股票交易,Liminatus Pharma LLC股票购买,Liminatus Pharma LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liminatus Pharma LLC(LIMN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liminatus Pharma LLC(LIMN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction